DS
KITE

David Shaw’s Kite Pharma, Inc. KITE Stock Holding History

David Shaw’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-39,106
Closed -$7.03M – 3897
2017
Q3 		$7.03M Buy
+39,106
New +$5.45M 0.01% 1151
2017
Q1 		– Sell
-10,282
Closed -$636K – 3758
2016
Q4 		$461K Sell
10,282
-55,204
-84% -$2.71M ﹤0.01% 2894
2016
Q3 		$3.66M Buy
65,486
+44,865
+218% +$2.5M 0.01% 1496
2016
Q2 		$1.03M Buy
20,621
+1,391
+7% +$68.3K ﹤0.01% 2390
2016
Q1 		$883K Buy
19,230
+2,100
+12% +$102K ﹤0.01% 2431
2015
Q4 		$1.06M Buy
17,130
+5,300
+45% +$373K ﹤0.01% 2596
2015
Q3 		$659K Sell
11,830
-5,870
-33% -$369K ﹤0.01% 2883
2015
Q2 		$1.08M Buy
17,700
+5,300
+43% +$302K ﹤0.01% 2655
2015
Q1 		$715K Buy
+12,400
New +$831K ﹤0.01% 2818

David Shaw's KITE Position: Q4 2017 in Review

David Shaw sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 39,106 shares — an estimated $7.03M sold.

David Shaw first reported a position in KITE in Q1 2015 and held it in 9 quarters. The position peaked at $7.03M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • David Shaw reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • David Shaw sold 39,106 Kite Pharma, Inc. shares in Q4 2017, an estimated $7.03M.
  • David Shaw first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 9 quarters.
  • David Shaw's Kite Pharma, Inc. position peaked at $7.03M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.